Structural insights are transforming how therapeutic antibodies are discovered, characterized, and engineered. With advances in cryo-electron microscopy (cryo-EM), researchers can now visualize antibody–antigen interactions at near-atomic resolution, revealing critical information about epitopes, binding mechanisms, and molecular architecture.
Join FairJourney Bio as we introduce our new state-of-the-art Cryo-EM Center of Excellence in San Diego, featuring two 5th-generation Titan Krios(TM) microscopes and an integrated structural biology platform.
In this webinar, we'll explore how cryo-EM is reshaping antibody discovery and engineering, enabling researchers to tackle challenging therapeutic targets, characterize complex antibody formats, and leverage structural insights to make more informed development decisions.
Discover how integrating advanced structural biology with FairJourney's antibody discovery and engineering capabilities can help accelerate the journey from target to therapeutic.
Featuring Insights from
Christopher Arthur
PhD
Christopher Arthur, PhD, got his start in cryo-EM in 1998 in the lab of Dr. Alok Mitra at The Scripps Research Institute (TSRI). He then went to work for Dr. Ron Milligan, also at TSRI, where he studied the structures of actomyosin and kinesin-microtubule complexes for a number of years. In 2003 he moved to the University of Colorado at Boulder to complete his PhD in Molecular, Cellular, and Developmental Biology in the lab of Dr. Michael Stowell. After that he returned to Scripps to do a joint postdoc with Dr. Nigel Unwin at the MRC and Dr. Ron Milligan at Scripps. In 2011 he left academia to take a position as a Titan Krios applications engineer with FEI Company. From 2011 to 2016 he worked his way up to Applications Manager for North America and finally to Customer Success Manager for cryo-TEM. Then in late 2016 he was recruited to Genentech as a Principal Systems Specialist to build and run their cryo-EM group. After great success there, he was recruited to Altos Labs in 2022 as Director of Cryo-EM to build and lead their cryo-EM group. In 2025 he joined FairJourney Bio as Head of Structural Biology to build and run their cryo-EM group. Christopher is co-author of over 40 publications and co-inventor of multiple patents.
Sponsored by
